Navamedic ASA announced that Olof Milveden is released from his duties as CEO of the Company. Mr. Milveden has been with the international pharma industry for almost thirty years, of which the last four years as CEO of Navamedic. Olof Milveden has requested a change in his duties, and he will remain with Navamedic as a strategic advisor.

The Board of Directors has appointed Håkan Josephsson as interim CEO of Navamedic until a permanent Chief Executive takes office. Mr. Josephsson is currently Managing Director of the Swedish subsidiary Navamedic AB and head of the group's Nordic operations. He has been with Navamedic for the past four years, and has over 25 years of pharma industry experience.